Second Generation FIT for Colorectal Cancer

Use Second Generation FIT for Colorectal cancer. This  is a serious and potentially life-threatening disease that affects thousands of people each year. It is the third most common cancer diagnosed in both men and women in the United States. However, when detected early, it is highly treatable, making regular screening essential for early detection and successful treatment.

The Second Generation FIT for Colorectal Cancer is a non-invasive screening test that has been developed to improve the accuracy and convenience of colorectal cancer screening. This test uses fecal immunochemical technology to detect the presence of blood in the stool, which can be an early indication of colorectal cancer.

Unlike other screening tests, the Second Generation FIT does not require any dietary or medication restrictions, and can be done at home. The test involves collecting a small stool sample using a collection device that is included in the kit. The sample is then sent to a laboratory for analysis.

The Second Generation FIT is highly accurate, with a reported sensitivity of over 90%. This means that it can detect even small amounts of blood in the stool, making it an effective tool for early detection of colorectal cancer.

The test is also convenient and easy to use, making it an ideal choice for individuals who may be hesitant to undergo more invasive screening procedures. Additionally, the Second Generation FIT is a cost-effective screening option that is covered by most insurance plans.

It is recommended that individuals between the ages of 45 and 75 undergo regular colorectal cancer screening. The frequency of screening will depend on a person’s individual risk factors, family history, and other factors.

In conclusion, the Second Generation FIT for Colorectal Cancer is a valuable tool for early detection and prevention of colorectal cancer. Its non-invasive nature, high accuracy, and convenience make it an ideal choice for individuals who want to ensure their colorectal health. Regular screening with the Second Generation FIT can help detect colorectal cancer in its early stages, when it is most treatable, and can ultimately save lives.